Release of myocardial depressant factor (MDF) during cardiopulmonary bypass (CPB): influence of corticosteroids (methylprednisolone) and protease inhibitor (aprotinin).
D000328:Adult; D000368:Aged; D007611:Aprotinin / Q000627:therapeutic use; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D008875:Middle Aged; D009201:Myocardial Depressant Factor / Q000097:blood*; D010455:Peptides / Q000097:blood*; D012773:Shock, Surgical / Q000097:blood* / Q000188:drug therapy
D009201:Myocardial Depressant Factor; D010455:Peptides; D008776:Methylprednisolone Hemisuccinate; D007611:Aprotinin